Kymera Therapeutics (NASDAQ:KYMR) Upgraded at Wells Fargo & Company
Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) was upgraded by stock analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research report issued on Monday,Benzinga reports. The firm presently has a $57.00 price objective on the stock, up from their previous price objective of $38.00. Wells Fargo […]
More Stories
Louisiana Gunman Kills at Least 8 Children in Morning Shooting Spree
By Jacki Thrapp At least eight children were killed during a shooting in Shreveport, Louisiana, on the morning of April...
US to Create 4000-Acre High-Tech Economic Security Zone in the Philippines
By Guy Birchall The United States and the Philippines are set to build a 4,000-acre industrial hub after Manila became...
Trump Says US Negotiators Will Travel to Pakistan for Peace Talks With Iran
By Tom Gantert President Donald Trump said on Sunday that U.S. representatives will arrive in Pakistan on Monday evening in...
Six Dead After Shooter Opens Fire in Kyiv
By Jacki Thrapp At least six people died on April 18 when a man opened fire in Kyiv’s Holosiivskyi district....
USDA Disqualifies 1,562 Retailers, Prevents $835 Million in Fraudulent SNAP Transactions
By Naveen Athrappully The U.S. Department of Agriculture’s Food and Nutrition Service has disqualified 1,562 retailers associated with the Supplemental...
Abbott Threatens $200 Million in Funding Cuts Across Texas’s Largest Cities Over ICE Policies
By Kimberly Hayek Texas Gov. Greg Abbott on April 16 threatened to cut more than $200 million in public safety...